Abiopharma

🔍 Holt Jason (Executive)

Company: UFP TECHNOLOGIES INC (UFPT)

Report Date: 2026-02-10

Detailed Transactions and Holdings:

• Acquired 657 shares of Common Stock, $.01 Par Value (Direct)
  Date: 2026-02-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,335.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,121 shares of Common Stock, $.01 Par Value (Direct)
  Date: 2026-02-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,456.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units granted on February 11, 2025, under the Issuer's 2003 Incentive Plan subject to satisfaction of performance targets that are to be settled solely in shares of common stock. The transaction date represents the date on which the Issuer's Compensation Committee determined the performance targets were achieved. The units vest with respect to one-third of the shares on March 1, 2026 and with respect to an additional one-third on each of March 1, 2027 and 2028, so long as the recipient is in the continuous employ of the Issuer through each such respective vesting date.
• F2: Represents stock unit awards granted on February 10, 2026, under the Issuer's 2003 Incentive Plan the vesting under which is solely time-based, that are to be settled solely in shares of common stock. The units vest with respect to one-third of the shares on March 1, 2027 and with respect to an additional one-third on each of March 1, 2028 and 2029, so long as the recipient is in the continuous employ of the Issuer through each such respective vesting date.